Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Colorectal Neoplasms

  Free Subscription


29.09.2025

1 Ann Oncol
10 Ann Surg Oncol
1 BMC Cancer
5 Br J Cancer
2 Br J Surg
1 Clin Cancer Res
1 Int J Cancer
1 J Natl Cancer Inst
10 J Surg Oncol
1 Nat Rev Cancer
1 Oncogene
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Oncol

  1. LEPAGE C, Phelip JM, Cany L, Barbier E, et al
    Effect of 5 years of CT-scan and CEA follow-up on survival endpoints in patients with colorectal cancer.
    Ann Oncol. 2025 Sep 17:S0923-7534(25)04701-5. doi: 10.1016/j.annonc.2025.
    PubMed         Abstract available


    Ann Surg Oncol

  2. KONG D, Li Y, Yin S, Tan Y, et al
    ASO Visual Abstract: Peritoneal Lavage Cytology Predicts Peritoneal Metastasis and is Associated with Poor Prognosis in Stage II-III Colorectal Cancer Patients.
    Ann Surg Oncol. 2025 Sep 20. doi: 10.1245/s10434-025-18368.
    PubMed        

  3. HEIL J, Sliwinski S, D'Haese J, Fangmann J, et al
    Textbook Outcome After Major Liver Resection for Primary and Secondary Liver Tumors at Specialized German Hepatobiliary Centers: Analysis of the StuDoQ Liver Registry.
    Ann Surg Oncol. 2025;32:7183-7194.
    PubMed         Abstract available

  4. CLEMENT E, Alam A, Lange C, Lin W, et al
    The Impact of Multidisciplinary Conference on Clinicians.
    Ann Surg Oncol. 2025;32:7344-7350.
    PubMed         Abstract available

  5. APEL R, Sulimani O, Perl G, Abitbol C, et al
    Israel's First Port-Based Hepatic Artery Infusion Program: Early Outcomes in Colorectal Liver Metastases.
    Ann Surg Oncol. 2025;32:7200-7208.
    PubMed         Abstract available

  6. ABOELMAATY S, Gomaa IA, Sileo A, Sassun R, et al
    The Impact of RAS/BRAF Mutation on Pathological Complete Response After Total Neoadjuvant Therapy in Rectal Cancer.
    Ann Surg Oncol. 2025;32:7326-7332.
    PubMed         Abstract available

  7. WANG A, Ying J, Zhang J, Zhu X, et al
    Simultaneous Vaginoplasty with Acellular Dermal Matrix and Pedicled Omental Flap and Pull-Through Colon-Anal Anastomosis for Low Rectal Cancer with Vaginal Invasion.
    Ann Surg Oncol. 2025;32:7351-7352.
    PubMed         Abstract available

  8. ZHUANG Z, Yang X, Zhang Y, Deng X, et al
    Discrepancies in the Reactivity of Mesorectal versus Lateral Lymph Nodes Post-Neoadjuvant Chemoradiotherapy for Rectal Cancer: Insights from Radiological and Pathological Perspectives.
    Ann Surg Oncol. 2025;32:7293-7303.
    PubMed         Abstract available

  9. LIU A, Reason EH, Sullivan BG, Wildman-Tobriner B, et al
    Circulating Tumor DNA as a Novel Prognostic Biomarker of Therapeutic Efficacy in Patients with Unresectable Colorectal Liver Metastases Treated with Hepatic Arterial Infusion.
    Ann Surg Oncol. 2025;32:7131-7140.
    PubMed         Abstract available

  10. OCHIAI K, Hida K, Yamaguchi T, Fukuda M, et al
    Risk Factors for and Oncologic Impact of Anastomotic Leakage After Sphincter-Preserving Proctectomy for Mid/Low Rectal Cancer: A Multi-institutional Cohort Study in Japan.
    Ann Surg Oncol. 2025;32:7315-7325.
    PubMed         Abstract available

  11. ZHAO J, Zheng P, Xu T, Feng Q, et al
    Preoperative Assessment of Lymph Node Metastasis in Rectal Cancer Using Deep Learning: Investigating the Utility of Various MRI Sequences.
    Ann Surg Oncol. 2025;32:7304-7314.
    PubMed         Abstract available


    BMC Cancer

  12. LIN PT, Wu YW
    Highly-accurate prediction of colorectal cancer through low abundance uncultivated genomes recovered using metagenomic co-assembly and binning approach.
    BMC Cancer. 2025;25.
    PubMed         Abstract available


    Br J Cancer

  13. YU H, Jin S, Zeng M, Yang Z, et al
    TIGIT antibody with PVR competitive ability enhances cancer immunotherapy and capable of eliciting anti-tumour immune memory.
    Br J Cancer. 2025;133:743-755.
    PubMed         Abstract available

  14. THONG MSY, Doege D, Koch-Gallenkamp L, Bertram H, et al
    Fatigue in long-term cancer survivors: prevalence, associated factors, and mortality. A prospective population-based study.
    Br J Cancer. 2025;133:831-843.
    PubMed         Abstract available

  15. CHANG YH, Bresnahan ST, Taylor Head S, Harrison TA, et al
    Isoform-level analyses of 6 cancers uncover extensive genetic risk mechanisms undetected at the gene-level.
    Br J Cancer. 2025;133:874-885.
    PubMed         Abstract available

  16. FENG Y, Zhu J, Ou C, Deng Z, et al
    Retraction Note: MicroRNA-145 inhibits tumour growth and metastasis in colorectal cancer by targeting fascin-1.
    Br J Cancer. 2025 Sep 19. doi: 10.1038/s41416-025-03209.
    PubMed        

  17. KAWAMURA H, Honda M, Nakayama Y, Oba K, et al
    Adverse events of postoperative adjuvant chemotherapy predict survival outcomes in locally advanced colorectal cancer: a pooled analysis of Japanese clinical trials.
    Br J Cancer. 2025 Sep 22. doi: 10.1038/s41416-025-03199.
    PubMed         Abstract available


    Br J Surg

  18. REESE T, Bjork D, Longva AMH, Kiim KS, et al
    Oncological safety of portal vein embolization without prior tumour clearance in the future liver remnant followed by one-stage hepatectomy for bilateral colorectal liver metastases.
    Br J Surg. 2025;112:znaf198.
    PubMed         Abstract available


  19. Covered versus uncovered endoluminal stenting in the acute management of obstructing colorectal cancer in the palliative setting: randomized clinical trial (CReST2).
    Br J Surg. 2025;112:znaf117.
    PubMed         Abstract available


    Clin Cancer Res

  20. SMABERS LP, Wensink GE, Verissimo CS, Doorn M, et al
    Patient-derived organoids predict treatment response in metastatic colorectal cancer.
    Clin Cancer Res. 2025 Sep 22. doi: 10.1158/1078-0432.CCR-25-1564.
    PubMed         Abstract available


    Int J Cancer

  21. VAN LANEN AS, Kok DE, Wesselink E, Derksen JWG, et al
    Pre- and post-diagnostic meat intake in relation to risk of recurrence and mortality among individuals with stage I-III colorectal cancer.
    Int J Cancer. 2025 Sep 18. doi: 10.1002/ijc.70113.
    PubMed         Abstract available


    J Natl Cancer Inst

  22. MEESTER RGS, Miller EA, Pinsky PF, Schoen RE, et al
    Contrasts in colorectal cancer incidence and mortality in screening trials of sigmoidoscopy versus colonoscopy (NordICC).
    J Natl Cancer Inst. 2025 Sep 14:djaf269. doi: 10.1093.
    PubMed         Abstract available


    J Surg Oncol

  23. THONG DW, Chakraborty P, Rajan R, Theophilus M, et al
    Adjuvant Radiotherapy in Incidental Positive Nodal Disease in Rectal Cancer-A Systemic Review.
    J Surg Oncol. 2025;132:622-632.
    PubMed         Abstract available

  24. UENO K, Hoshino N, Hida K, Nomura A, et al
    Long-Term Urinary Dysfunction and Impact on Quality of Life After Rectal Cancer Surgery: A Prospective Multicenter Observational Study.
    J Surg Oncol. 2025;132:556-564.
    PubMed         Abstract available

  25. ROGERS P, Dourado J, Emile SH, Wignakumar A, et al
    Association Between Mesorectal Grade and Oncologic Outcomes in Rectal Cancer: A Systematic Review and Meta-Analysis.
    J Surg Oncol. 2025;132:437-446.
    PubMed         Abstract available

  26. HABERMANN A, Lee L, Martey S, Siddiqui A, et al
    Local and National Trends in Emergency Presentation of Colon and Rectal Cancer.
    J Surg Oncol. 2025;132:588-598.
    PubMed         Abstract available

  27. BALDO A, Chatzipanagiotou OP, Kawashima J, Spolverato G, et al
    The Role of KRAS Status Among Patients Undergoing Staged Versus Simultaneous Resection for Synchronous Colorectal Liver Metastases.
    J Surg Oncol. 2025;132:654-665.
    PubMed         Abstract available

  28. BARNES S, Emile SH, Wignakumar A, Dourado J, et al
    Outcomes of Organ-Preserving Local Excision Compared to Radical Resection in Stage I Early-Onset Rectal Cancer: A Propensity-Score SEER-Based Analysis.
    J Surg Oncol. 2025;132:599-606.
    PubMed         Abstract available

  29. ZHAO B, Truong A
    The Slow Adoption of Neoadjuvant Treatment for Clinical T4b Colon Cancer: A National Cancer Database Analysis.
    J Surg Oncol. 2025 Sep 19. doi: 10.1002/jso.70093.
    PubMed         Abstract available

  30. SHIN D, Son NH, Jeong WK, Baek SK, et al
    Preoperative Strength, Assistance in Walking, Rising From a Chair, Climbing Stairs, and Falls (SARC-F) Score Predicts Adjuvant Chemotherapy Discontinuation in Patients With Colorectal Cancer.
    J Surg Oncol. 2025 Sep 20. doi: 10.1002/jso.70097.
    PubMed         Abstract available

  31. JIN G, Zhao G, You J, Li M, et al
    Downregulation of CMTM4 and Its Tumor-Suppressive Role in Colorectal Cancer: Insights From Expression and Survival Analyses.
    J Surg Oncol. 2025 Sep 22. doi: 10.1002/jso.70089.
    PubMed         Abstract available

  32. GOSAVI R, Yap R, Bell S, Wilkins S, et al
    Anastomotic Leak Following Colon Cancer Resection: An Independent Predictor of Non-Oncologic Mortality and Morbidity.
    J Surg Oncol. 2025 Sep 22. doi: 10.1002/jso.70100.
    PubMed         Abstract available


    Nat Rev Cancer

  33. KENNEL KB, Greten FR
    The immune microenvironment of colorectal cancer.
    Nat Rev Cancer. 2025 Sep 22. doi: 10.1038/s41568-025-00872.
    PubMed         Abstract available


    Oncogene

  34. LIN P, Lin C, Teng Z, Liu S, et al
    USP10-mediated Ku70/80 stabilization inhibits PANoptosis and promotes chemoresistance in colorectal cancer.
    Oncogene. 2025 Sep 18. doi: 10.1038/s41388-025-03570.
    PubMed         Abstract available


    PLoS One

  35. ALSHAHRANI MM
    Structural stability-guided scaffold hopping and computational modeling of tankyrase inhibitors targeting colorectal cancer.
    PLoS One. 2025;20:e0332798.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.